Wnt Signaling Pathway in Tumor Biology
Genes · 2024
DOI: 10.3390/genes15121597 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2024. Verfasst von Sabina Iluta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj Napoca, Romania. Hauptthemen laut MEDLINE: Neoplasms, Wnt Signaling Pathway. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hatieganu University—School of Doctoral Studies, Romanian National Ministry of Research, Innovation and Digitalization, a collaborative grant between Romania and Moldova (2024–2025), Romanian Research Ministry—PNRR 2024–2026.
Abstract (Originalsprache)
Relapse and metastasis are the major challenges that stand in the way of cancer healing and survival, mainly attributed to cancer stem cells (CSCs). Their capabilities of self-renewal and tumorigenic potential leads to treatment resistance development. CSCs function through signaling pathways such as the Wnt/β-catenin cascade. While commonly involved in embryogenesis and adult tissues homeostasis, the dysregulation of the Wnt pathway has direct correlations with tumorigenesis, metastasis, and drug resistance. The development of therapies that target CSCs and bulk tumors is both crucial and urgent. However, the extensive crosstalk present between Wnt and other signaling networks (Hedgehog and Notch) complicates the development of efficient long-term therapies with minimal side-effects on normal tissues. Despite the obstacles, the emergence of Wnt inhibitors and subsequent modulation of the signaling pathways would provide dynamic therapeutic approaches to impairing CSCs and reversing resistance mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj Napoca, Romania.
- Medfuture Research Center for Advanced Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400347 Cluj Napoca, Romania.
- Department of Hematology, Nicolae Testemitanu University of Medicine and Pharmacy, 2004 Chisinau, Moldova.
- Department of Hematology, Ion Chiricuta Oncology Institute, 400015 Cluj Napoca, Romania.
ORCID-Profile: Madalina Nistor, Sanda Buruiana
Förderung
- Iuliu Hatieganu University—School of Doctoral Studies
- Romanian National Ministry of Research, Innovation and Digitalization, a collaborative grant between Romania and Moldova (2024–2025)
- Romanian Research Ministry—PNRR 2024–2026
Zitieren
APA
Iluta, S., Nistor, M., Buruiana, S., & Dima, D. (2024). Wnt Signaling Pathway in Tumor Biology. Genes. https://doi.org/10.3390/genes15121597
Vancouver
Iluta S, Nistor M, Buruiana S, Dima D. Wnt Signaling Pathway in Tumor Biology. Genes. 2024. doi:10.3390/genes15121597
BibTeX
@article{Iluta2024,
author = {Iluta, Sabina and Nistor, Madalina and Buruiana, Sanda and Dima, Delia},
title = {Wnt Signaling Pathway in Tumor Biology},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15121597}
}
EUVIMED